Willow Labs Settles False Advertising Claims for $22 Million

Willow Labs and its marketers will stop making claims that its light therapy device, the Willow Curve, treats chronic, severe pain and associated inflammation, under a $22 million settlement with the Federal Trade Commission (FTC).

The FTC alleged that the marketers promoted the device nationwide as a “smart” device that is “clinically proven,” even though they lacked scientific evidence to support the claims.

They also falsely claimed that Willow Curve, a curved device that emits infrared and invisible light, was approved by the FDA to diagnose and treat chronic, severe pain and reduce inflammation, according to the FTC.